Trimethobenzamide Hydrochloride (Tigan) (Injection) 100 mg/mL

Trimethobenzamide Hydrochloride (Tigan) injection 100 mg/mL is an antiemetic medication used to relieve nausea and vomiting. This prescription treatment is administered via injection for fast-acting relief. Ideal for managing nausea symptoms when oral options are not feasible.

Strength

100 mg/mL

Manufacturer / TM Owner

General Injectables & Vaccines, Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trimethobenzamide Hydrochloride (Tigan) is commonly used to treat nausea and vomiting in adults and children. It works by blocking signals in the brain that trigger nausea, making it useful for motion sickness, post-surgery recovery, and other conditions causing nausea. Patients often ask, 'what is Trimethobenzamide Hydrochloride used for' to address persistent nausea symptoms.

Side Effects

This medication helps reduce feelings of nausea and prevents vomiting episodes. Users may experience relief within minutes to hours after injection, depending on individual response. Common effects include decreased urge to vomit and improved comfort during nausea-inducing situations.

Precautions & Warnings

Keep Trimethobenzamide Hydrochloride (Tigan) injections refrigerated or at room temperature as directed by a healthcare provider. Avoid exposure to extreme heat or freezing. Always use as prescribed and report any unusual reactions to a medical professional promptly.

Avoid Interactions

Trimethobenzamide Hydrochloride (Tigan) may interact with alcohol and other central nervous system depressants. Caution is advised when combining with medications that affect dopamine levels or anticholinergic drugs. Consult a healthcare provider before mixing with other treatments to avoid potential interactions.

Frequently Asked Questions

This medication is given as an intramuscular injection by a healthcare professional. The dosage and frequency depend on the patient's condition and medical advice.

Yes, it is approved for pediatric use under medical supervision. Dosage adjustments may be required based on age and weight.

Possible effects include drowsiness, dizziness, and injection site discomfort. Severe reactions should be reported to a doctor immediately.

Yes, this medication is available by prescription only. Consult a healthcare provider for proper evaluation and dosing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.